These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38283199)

  • 21. Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells.
    Pakravan K; Mossahebi-Mohammadi M; Ghazimoradi MH; Cho WC; Sadeghizadeh M; Babashah S
    J Transl Med; 2022 Dec; 20(1):559. PubMed ID: 36463188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination Nano-Delivery Systems Remodel the Immunosuppressive Tumor Microenvironment for Metastatic Triple-Negative Breast Cancer Therapy.
    Bai L; Liu H; You R; Jiang X; Zhang T; Li Y; Shan T; Qian Z; Wang Y; Liu Y; Li C
    Mol Pharm; 2024 May; 21(5):2148-2162. PubMed ID: 38536949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
    Jiang Y; Wang K; Lu X; Wang Y; Chen J
    Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA 603 acts as a tumor suppressor and inhibits triple-negative breast cancer tumorigenesis by targeting elongation factor 2 kinase.
    Bayraktar R; Pichler M; Kanlikilicer P; Ivan C; Bayraktar E; Kahraman N; Aslan B; Oguztuzun S; Ulasli M; Arslan A; Calin G; Lopez-Berestein G; Ozpolat B
    Oncotarget; 2017 Feb; 8(7):11641-11658. PubMed ID: 28036267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
    Zheng S; Li M; Miao K; Xu H
    J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
    Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
    Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delivery of miR-424-5p via Extracellular Vesicles Promotes the Apoptosis of MDA-MB-231 TNBC Cells in the Tumor Microenvironment.
    Zhou Y; Yamamoto Y; Takeshita F; Yamamoto T; Xiao Z; Ochiya T
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer.
    Deepak KGK; Vempati R; Nagaraju GP; Dasari VR; S N; Rao DN; Malla RR
    Pharmacol Res; 2020 Mar; 153():104683. PubMed ID: 32050092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell RNA-sequencing uncovers compound kushen injection synergistically improves the efficacy of chemotherapy by modulating the tumor environment of breast cancer.
    Liu X; Bai M; Li H; Ye P; Duan X; Wu C; Huang Z; Lu S; Zhang J; Zhao Z; Guo F; You R; Qin W; Wang W; Han A; Shen L; Wang Y; Zhao Z; Luo H; Wu J
    Front Immunol; 2022; 13():965342. PubMed ID: 36389835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M
    Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment.
    Harnoss JM; Le Thomas A; Reichelt M; Guttman O; Wu TD; Marsters SA; Shemorry A; Lawrence DA; Kan D; Segal E; Merchant M; Totpal K; Crocker LM; Mesh K; Dohse M; Solon M; Modrusan Z; Rudolph J; Koeppen H; Walter P; Ashkenazi A
    Cancer Res; 2020 Jun; 80(11):2368-2379. PubMed ID: 32265225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of miR-3182 and miR-3143 target genes involved in the cell cycle as a novel approach in TNBC treatment: A systems biology approach.
    Khazaei-Poul Y; Mirmotalebisohi SA; Zali H; Molavi Z; Mohammadi-Yeganeh S
    Chem Biol Drug Des; 2023 Mar; 101(3):662-677. PubMed ID: 36310371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy.
    Yan G; Xiao Q; Zhao J; Chen H; Xu Y; Tan M; Peng L
    J Control Release; 2024 Mar; 367():425-440. PubMed ID: 38295998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineering macrophage-derived exosomes for targeted chemotherapy of triple-negative breast cancer.
    Li S; Wu Y; Ding F; Yang J; Li J; Gao X; Zhang C; Feng J
    Nanoscale; 2020 May; 12(19):10854-10862. PubMed ID: 32396590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synchronous targeted delivery of TGF-β siRNA to stromal and tumor cells elicits robust antitumor immunity against triple-negative breast cancer by comprehensively remodeling the tumor microenvironment.
    Yang M; Qin C; Tao L; Cheng G; Li J; Lv F; Yang N; Xing Z; Chu X; Han X; Huo M; Yin L
    Biomaterials; 2023 Oct; 301():122253. PubMed ID: 37536040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circ_0000520 contributes to triple-negative breast cancer progression through mediating the miR-1296/ZFX axis.
    Zhou Y; Ma G; Peng S; Tuo M; Li Y; Qin X; Yu Q; Kuang S; Cheng H; Li J
    Thorac Cancer; 2021 Sep; 12(18):2427-2438. PubMed ID: 34324278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple negative aggressive phenotype controlled by miR-135b and miR-365: new theranostics candidates.
    Bertoli G; Cava C; Corsi F; Piccotti F; Martelli C; Ottobrini L; Vaira V; Castiglioni I
    Sci Rep; 2021 Mar; 11(1):6553. PubMed ID: 33753785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial.
    Stevic I; Müller V; Weber K; Fasching PA; Karn T; Marmé F; Schem C; Stickeler E; Denkert C; van Mackelenbergh M; Salat C; Schneeweiss A; Pantel K; Loibl S; Untch M; Schwarzenbach H
    BMC Med; 2018 Oct; 16(1):179. PubMed ID: 30301470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyaluronic acid engrafted metformin loaded graphene oxide nanoparticle as CD44 targeted anti-cancer therapy for triple negative breast cancer.
    Basu A; Upadhyay P; Ghosh A; Bose A; Gupta P; Chattopadhyay S; Chattopadhyay D; Adhikary A
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129841. PubMed ID: 33412224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modified bone marrow mesenchymal stem cells derived exosomes loaded with MiRNA ameliorates non-small cell lung cancer.
    Yang M; Zhou W; Han X; Xu M; Wang Z; Shi M; Shi Y; Yu Y
    J Cell Mol Med; 2024 Sep; 28(18):e70115. PubMed ID: 39320274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.